US equivalence "impossible" in forseeable future - Allianz CRO


The US cannot be granted equivalence under the European Solvency II directive, and this will lead to a competitive disadvantage for European insurance groups, according to Tom Wilson, chief risk officer for Allianz.

The lack of a market-consistent framework regulatory framework in the US ishe principal driver stopping the regulatory regime obtaining the preferential regulatory treatment, rather than its state-based organisation and absence of a national regulator, according to the CRO of the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: